Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Capital/Financing Update 2003

May 18, 2003

65124_rns_2003-05-18_4a235ecf-c056-414f-82f6-b0f25ad685f4.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002.

Name of entity

IMUGENE LIMITED

$ABN$

99 009 179 551

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\pmb{\mathsf{I}}$ +Class of +securities issued or to be issued

Ordinary shares

  • $\overline{2}$ Number of *securities issued or to be 121,729 issued (if known) or maximum number which may be issued
  • 3 Principal terms of the "securities (eg, if options, exercise price and expiry date; if partly paid "securities, the amount outstanding and due dates for payment; if "convertible securities, the conversion price and dates for conversion)

Fully paid ordinary shares

+ See chapter 19 for defined terms.

4 Do the "securities rank equally in all
respects from the date of allotment with
an existing class of quoted securities?
If the additional securities do not rank
equally, please state:
• the date from which they do
the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
Yes
5 Issue price or consideration 11.25 cents per Option exercise price
6 Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly identify
those assets)
Conversion of 121,729 Unlisted Options into
121,729 Ordinary Shares (IMU).
7 Dates of entering securities into
uncertificated holdings or despatch of
certificates
19 May 2003
Number * Class
8 Number and " class of all " securities"
quoted on ASX (including
the
securities in clause 2 if applicable)
77,815,588 Ordinary shares

$\pm$ See chapter 19 for defined terms.

J) Number and class of all securities
not quoted on ASX (including the
securities in clause 2 if applicable)
Number *Class
4,191,611 Options exercisable at
11.25 cents
4,633,333 Performance Options

$10\,$ Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Not Applicable

Part 2 - Bonus issue or pro rata issue

$\mathbf{H}$ Is security holder approval required? Not Applicable
12 renounceable or non-
the
issue
Is.
renounceable?
Not Applicable
13 Ratio in which the "securities will be
offered
Not Applicable
4 " Class of " securities to which the offer
relates
Not Applicable
15 Record date to determine entitlements Not Applicable
16 Will holdings on different registers (or
subregisters)
be
aggregated
fог
calculating entitlements?
Not Applicable
17 Policy for deciding entitlements
in
relation to fractions
Not Applicable
18 Names of countries in which the entity
has "security holders who will not be
sent new issue documents
Note: Security holders must be told how their
entitiements are to be dealt with.
Cross reference: rule 7.7.
Not Applicable
19 Closing date for receipt of acceptances
or renunciations
Not Applicable

$\pm$ See chapter 19 for defined terms.

20 Names of any underwriters Not Applicable
21 Amount of any underwriting fee or
commission
Not Applicable
22 Names of any brokers to the issue Not Applicable
23. Fee or commission payable to the
broker to the issue
Not Applicable
24 Amount of any handling fee payable to
brokers who lodge acceptances or
renunciations on behalf of 'security
holders
Not Applicable
25. If the issue is contingent on security
holders' approval, the date of the
meeting
Not Applicable
26 Date entitlement and acceptance form
and prospectus or Product Disclosure
Statement will be sent to persons
entitled
Not Applicable
27 If the entity has issued options, and the
holders
entitle
option
terms
ťΟ
participate on exercise, the date on
which notices will be sent to option
holders
Not Applicable
28. Date rights trading will begin (if Not Applicable
applicable)
29 trading will end (if Not Applicable
Date rights
applicable)
30 How do security holders sell their
entitlements in full through a broker?
Not Applicable
31 How do * security holders sell part of
their entitlements through a broker and
accept for the balance?
Not Applicable

$\pm$ See chapter 19 for defined terms.

32 How do "security holders dispose of their entitlements (except by sale through a broker)?

33 Despatch date Not Applicable

Not Applicable

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities (tick one)
  • $(a)$ Securities described in Part 1
(b) All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

(If the additional securities do not form a new class, go to $43$ )

Tick to indicate you are providing the information or
documents
If the $\degree$ securities are $\degree$ equity securities, the names of the 20 largest holders of the additional
securities, and the number and percentage of additional "securities held by those holders"
If the $\degree$ securities are $\degree$ equity securities, a distribution schedule of the additional $\degree$ securities setting
out the number of holders in the categories
$1 - 1.000$
$1.001 - 5.000$
5,001 - 10,000
10,001 - 100,000
100,001 and over

37

35

36

A copy of any trust deed for the additional "securities

(now go to 43)

+ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

38 Number
οf
securities
for
which
* quotation is sought
Not Applicable
39 Class of $\vec{ }$ securities for which quotation
is sought
Not Applicable
40 Do the "securities rank equally in all
respects from the date of allotment with
an existing "class of quoted "securities?
If the additional securities do not rank
Not Applicable
equally, please state:
the date from which they do
the extent to which they participate
for the next dividend, (in the case of
a trust, distribution) or interest
payment
the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
41 Reason for request for quotation now Not Applicable
Example: In the case of restricted securities, end of
restriction period
(if issued upon conversion of another
security, clearly identify that other
security)
Number $^{\circ}$ Class
42 Number and class of all securities
quoted on ASX (including the securities
in clause 38)
Not Applicable

$(now go to 43)$

$\pm$ See chapter 19 for defined terms.

All entities

Fees

43 Payment method (tick one)
Cheque attached
Electronic payment made
Note: Payment may be made electronically if Appendix 3B is given to ASX electronically at the same time.
Periodic payment as agreed with the home branch has been arranged
Note: Arrangements can be made for employee incentive schemes that involve frequent issues of securities.

Ouotation agreement

  • $\mathbf{I}$ "Quotation of our additional "securities is in ASX's absolute discretion. ASX may quote the "securities on any conditions it decides.
  • $\overline{2}$ We warrant the following to ASX.
  • The issue of the "securities to be quoted complies with the law and is not for $\bullet$ an illegal purpose.
  • There is no reason why those "securities should not be granted" quotation. $\bullet$
  • An offer of the "securities for sale within 12 months after their issue will not $\bullet$ require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to elve this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any "securities to be quoted and that no-one has any right to return any "securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the 'securities be quoted.
  • We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the "securities to be quoted, it has been provided at the time that we request that the "securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the 'securities to be quoted under section 1019B of the Corporations Act at the time that we request that the "securities be quoted.

+ See chapter 19 for defined terms.

  • $\overline{\mathbf{3}}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before "quotation of the 'securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: . . . . . Date: 19 May 2003
( Director /Company secretary)

MARK PEARCE Print name:


+ See chapter 19 for defined terms.